Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 1, 2005, Pages 75-85

  Abellan, Rosario ^a,b   Ventura, Rosa ^a,b   Pichini, Simona ^c   Pascual, Jose A ^a,b   Pacifici, Roberta ^c   Di Carlo, Simonetta ^c   Bacosi, Antonella ^c   Seguar, Jordi ^a,b   Zuccaro, Piergiorgio ^c  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Growth hormone; Immunoassays; Insulin like growth factor I (IGF I); Procollagen type III peptide (P III P); Recombinant human growth hormone (rhGH) biomarkeres; Validation

Indexed keywords

BIOLOGICAL MARKER; HUMAN GROWTH HORMONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C;

ADOLESCENT; ADULT; ANALYTICAL PARAMETERS; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG MISUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; FREEZE THAWING; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; REFERENCE VALUE; REPRODUCIBILITY; SPORT; STANDARDIZATION; STORAGE; VALIDATION PROCESS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; CRYOPRESERVATION; DOPING IN SPORTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; IMMUNOASSAY; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; RADIOIMMUNOASSAY; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 14244267303     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.012     Document Type: Article

References (29)

1. Wallace JD, Cuneo RC, Baxter R, Orskov H, Keay N, Pentecost C, et al. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab 1999;84:3591-601.
2. Wallace JD, Cuneo RC, Lundberg PA, Rosen T, Jorgensen JO, Longobardi S, et al. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab 2000;85:124-33.
3. Longobardi S, Keay N, Ehrnborg C, Cittadini A, Dall R, Boroujerdi MA, et al. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab 2000;85:1505-12.
4. World Anti-Doping Agency. The 2004 Prohibited List. International Standard World Anti-Doping Code (update 25 November 2003).
5. Saugy M, Cardis C, Rivier L, Brisson G, Ayotte C, Hemmersbach P, et al. Urinary human growth hormone (U-hGH): II. Measurements in competition test: more the expression of the renal function than the endocrinological status. In: Donike M, Geyer H, Gotzman A, Mareck-Engelke U, editors. Recent advances in doping analysis (2). Proceedings of the 12th Cologne Workshop on Dope Analysis. Hansen, Köln: Sport and Buch Strauß - Edition Sport, 1995:223-33.
6. Saugy M, Cardis C, Rivier L. Urinary human growth hormone (U-hGH): I. Measurements in non-athletes volunteers after intra-muscular or subcutaneous hGH injections. In: Donike M, Geyer H, Gotzman A, Mareck-Engelke U, editors. Recent advances in doping analysis (2). Proceedings of the 12th Cologne Workshop on Dope Analysis. Hansen, Köln: Sport and Buch Strauß - Edition Sport, 1995:213-22.
7. Cuneo R, Wallace J, Sonksen P. Growth hormone abuse in elite athletes. In: Karch S, editor. Drug abuse handbook. Boca Raton, Florida: CRC Press, 1998:690-710.
8. Breier B, Gallaher B, Gluckman P. Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J Endocrinol 1991;128:347-57.
9. Saggese G, Baroncelli GI, Federico G, Bertelloni S. Effects of growth hormone on phosphocalcium homeostasis and bone metabolism. Horm Res 1995;44(Suppl 3):55-63.
10. Niemela O. Collagen breakdown products as markers of fibrosis and cirrhosis. Alcohol Alcohol Suppl 1994; 2:345-52.
11. Nguyen UN, Mougin F, Simon-Rigaud ML, Rouillon JD, Marguet P, Regnard J. Influence of exercise duration on serum insulin-like growth factor and its binding proteins in athletes. Eur J Appl Physiol 1998;78:533-7.
12. Eliakim A, Brasel JA, Brastow TJ, Mohan S, Cooper DM. Peak oxygen uptake, muscle volume, and the growth hormone-insulin-like growth factor-I axis in adolescent males. Med Sci Sports Exerc 1998;30:512-7.
13. Eliakim A, Brasel JA, Mohan S, Wong WLT, Cooper DM. Increased physical activity and the growth hormone-IGF-I axis in adolescent males. Am J Physiol 1998;275:R308-14.
14. Snow CM, Rosen CJ, Robinson TL. Serum IGF-I is higher in gymnasts than runners and predicts bone and lean mass. Med Sci Sports Exerc 2000;32;1902-7.
15. Marx JO, Ratamess NA, Nindl BC, Gotshalk LA, Volek JS, Dohi K, et al. Low-volume circuit versus high-volume periodized resistance training in women. Med Sci Sports Exerc 2001;33:635-43.
16. Borst SE, De Hoyos DV, Garzarella L, Vincent K, Pollock BH, Lowenthal DT, et al. Effects of resistance training on insulin-like growth factor-I and IGF binding proteins. Med Sci Sports Exerc 2001;33:648-53.
17. Dall R, Lance KHW, Kjaer M, Jorgensen JOL, Christiansen JS, Orskov H, et al. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. J Clin Endocrinol Metab 2001;86:669-74.
18. Ehrnborg C, Lange KH, Christiansen JS, Lundberg P-A, Baxter RC, Boroujerdi MA, et al. The growth hormone/insulin-like factor-I axis hormones and bone markers in elite athletes in response to maximum exercise test. J Clin Endocrinol Metab 2003;88:394-401.
19. Manetta J, Brun JF, Fedou C, Maïmoun L, Prefaut C, Mercier J. Serum levels of insulin-like factor-I (IGF-I), and IGF-binding proteins-1 and -3 in middle aged and young athletes versus sedentary men: relationship with glucose disposal. Metabolism 2003;52:821-6.
20. Takala TE, Vuori J, Anttinen H, Väänänen K, Myllylä R. Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in the concentration of type III procollagen aminopropeptide in human serum. Pflügers Arch 1986;407:500-3.
21. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988;34:715-8.
22. Takala TE, Vuori JJ, Rahkila PJ, Hakala EO, Karpakka JA, Alen EO, et al. Carbonic anhydrase III and collagen markers in serum following cross-country skiing. Med Sci Sports Exerc 1989;21:593-7.
23. Virtanen P, Viitasalo JT, Vuori J, Väänänen K, Takala TE. Effect of concentric exercise on serum muscle and collagen markers. J Appl Physiol 1993;75:1272-7.
24. Chestnut RE, Quarmby V. Evaluation of total IGF-I assay methods using samples from type I and type II diabetic patients. J Immunol Methods 2002;259:11-24.
25. Fleiss JL. The design and analysis of clinical experiments. New York: Wiley, 1986.
26. Passing H, Bablok W. A new biomedical method procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983;21:709-20.
27. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician 1983;32:307-17.
28. Waters DL, Qualls CR, Dorin R, Veldhuis JD, Baumgartner RN. Increased pulsatility, process irregularity and nocturnal trough concentrations of growth hormone in amenorrheic compared to eumenorrheic athletes. J Clin Endocrinol Metab 2001;86:1013-9.
29. Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994;4(Suppl 1):11-9.